KEAP1 loss-of-function (LOF) and NFE2L2 gain-of-function (GOF) mutations exhibited a mutually exclusive pattern, demonstrating that the overexpression of NRF2 may contribute as pivotal mechanism in the selection of specific cancers or stages of tumor progression, including lung cancer [54]. This evidence concerns the gene NFE2L2 and lung carcinoma.